Lord & Richards Wealth Management LLC Has $778,000 Stock Holdings in Chemed Corporation $CHE

Lord & Richards Wealth Management LLC trimmed its stake in shares of Chemed Corporation (NYSE:CHE) by 47.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,818 shares of the company’s stock after selling 1,659 shares during the quarter. Lord & Richards Wealth Management LLC’s holdings in Chemed were worth $778,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in CHE. Smartleaf Asset Management LLC increased its position in Chemed by 71.4% during the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after purchasing an additional 25 shares during the period. First Horizon Corp acquired a new position in shares of Chemed in the 3rd quarter worth approximately $31,000. Pilgrim Partners Asia Pte Ltd bought a new stake in shares of Chemed in the 3rd quarter valued at $45,000. HM Payson & Co. boosted its stake in shares of Chemed by 35.5% in the 3rd quarter. HM Payson & Co. now owns 103 shares of the company’s stock valued at $46,000 after purchasing an additional 27 shares during the last quarter. Finally, Geneos Wealth Management Inc. increased its position in shares of Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after buying an additional 76 shares during the period. 95.85% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on CHE shares. Zacks Research downgraded shares of Chemed from a “hold” rating to a “strong sell” rating in a research note on Wednesday, March 4th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Jefferies Financial Group downgraded Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Oppenheimer lowered their price objective on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research report on Friday, February 27th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and issued a $422.00 price objective (down from $572.00) on shares of Chemed in a research note on Friday, February 27th. Two analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $498.00.

Chemed Stock Up 1.4%

Shares of CHE stock opened at $373.63 on Tuesday. The firm has a 50 day moving average of $426.58 and a 200-day moving average of $434.63. The company has a market cap of $5.14 billion, a price-to-earnings ratio of 20.34, a price-to-earnings-growth ratio of 1.46 and a beta of 0.46. Chemed Corporation has a 52 week low of $365.20 and a 52 week high of $623.60.

Chemed (NYSE:CHE) last released its earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.02 by ($0.60). The company had revenue of $639.34 million for the quarter, compared to analyst estimates of $659.09 million. Chemed had a net margin of 10.48% and a return on equity of 25.66%. The firm’s revenue was down .1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.83 EPS. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. Analysts anticipate that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, February 23rd were given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend was Monday, February 23rd. Chemed’s dividend payout ratio is 13.06%.

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Thursday, March 12th. The stock was sold at an average price of $403.18, for a total value of $806,360.00. Following the completion of the sale, the chief executive officer directly owned 93,719 shares in the company, valued at $37,785,626.42. This trade represents a 2.09% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 3.29% of the stock is owned by company insiders.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.